Do you have dry macular degeneration (AMD)?

evaluating ORACEA® (40 mg doxycycline) for macular degeneration.

Who is eligible for this clinical trial?

You may qualify for this study if:

  • You are at least 55 years of age

  • You have geographic atrophy (advanced dry macular degeneration) in at least one eye

What will happen if I am in this clinical trial?

Participation in this study requires 8 visits and 4 telephone calls over about 31 months. Eligible paricipants are randomly assigned (like the flip of a coin) to take either ORACEA® (40 mg doxycycline) or placebo once daily for 24 months.

Contact Us

For more information about the study, click here or click the envelope icon below.


The following clinics are participating in this study:

▲ Hide locations

▲ Hide locations